SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries
SaudiVax, a leading biopharmaceutical company in Saudi Arabia, Minapharm Pharmaceuticals, a premier biopharmaceutical company and global provider of proprietary technologies headquartered in Egypt with multiple subsidiaries in Berlin, and MiGenTra GmbH (https://www.MiGenTra.com/), a healthcare transforming medicines company headquartered in Berlin, today announced the signing on 26th September 2023 of a Memorandum of Understanding (MoU) for the […]
Continue Reading